Thierry Gendre
Paris 12 Val de Marne University
9 Papers
7 Citations
Thierry Gendre is an academic researcher from Paris 12 Val de Marne University. The author has contributed to research in topics: Medicine & Transthyretin. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series.
L. Cleret de Langavant,Aimée Petit,Q.T.R. Nguyen,Thierry Gendre,Jihene Abdelhedi,Abdenour Djellaoui,Lilia Seddik,L. Lim,Frederique Faugeras,H. Salhi,Abir Wahab,Laura Fechtenbaum,A. Dormeuil,Hassan Hosseini,Katia Youssov,Gilles Fénelon,Blanche Bapst,P. Brugieres,T. Tuilier,E. Kalsoum,M.-B. Matignon,J. Oniszczuk,S. Gallien,W. Vindrios,Giovanna Melica,A.-L. Scain,R. Esser,L. Rostain,Constance Guillaud,G. Dubos-Lascu,N. Saada,H. Guillet,Mehdi Khellaf,Benjamin Bardel,Samar S. Ayache,Jean-Pascal Lefaucheur,Jean-Michel Pawlotsky,Slim Fourati,Anne-Catherine Bachoud-Lévi +38 more
TL;DR: In this paper, a case series of patients with acute neurological disorders associated with SARS-CoV-2 infection from medicine departments of an academic center in Paris area were collected between March 15th and May 15th 2020.
14
Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy.
TL;DR: Management of autonomic dysfunction in patients with hAATR is feasible and can result in improved qualify of life, and novel disease-modifying treatments for hA ATR may contribute to improve autonomics dysfunction, although specific studies are required.
Prévalence et caractéristiques des polyradiculoneuropathies démyélinisantes associées au Brentuximab-Vedotin. Une étude de cohorte rétrospective
Arthur Matthys,F. Le Bras,Benjamin Bardel,Muriel Carvalho,S. Oro,Violaine Planté-Bordeneuve,Thierry Gendre +6 more
TL;DR: In this paper , a cohort of patients with Brentuximab-vedotin (BV) associated with neuropathies axonales sensitives réversibles (NC-BV), mais des polyradiculoneuropathies démyélinisantes sévères (PRNDs) répondant to l'immunothérapie sont décrites.
Étude pilote du taux plasmatique de la chaîne légère du neurofilament dans les neuropathies paraprotéinémiques à IgM avec ou sans activité anti-MAG
Cécile Even,Thierry Gendre,Farida Gorram,François A. Lemonnier,Benjamin Bardel,Jean-Pascal Lefaucheur,Violaine Planté-Bordeneuve +6 more
TL;DR: In this paper , the neuropathies paraprotéinémiques à IgM (NP-IgM) sont fréquemment démyélinisantes, i.e., a dégénérescence axonale survient secondairement and pourrait être quantifiée by le taux plasmatique de la chaîne légère du neurofilament (pNfL).